期刊文献+

铜蓝蛋白、鳞状细胞癌相关抗原与慢性肾功能衰竭的关系及对病情进展的预测价值研究 被引量:1

The Relationship between Ceruloplasmin,Squamous Cell Carcinoma Antigen and Chronic Renal Failure and The Predictive Value of Disease Progression
原文传递
导出
摘要 目的:分析铜蓝蛋白(CER)、鳞状细胞癌相关抗原(SCCA)与慢性肾功能衰竭的关系及对病情进展的预测价值。方法:选择我院自2019年4月至2021年4月接诊的169例慢性肾功能衰竭患者作为研究对象,根据24 h尿白蛋白定量分为微量白蛋白尿组(<200 mg/24 h,102例)和大量白蛋白尿组(>200 mg/24 h,67例)。比较两组各项实验室指标及血清CER、SCCA水平,分析CER、SCCA与慢性肾功能衰竭患者肾功能指标的关系。随访12个月,观察病情进展,使用受试者工作特征曲线(ROC)评价血清CER联合SCCA对病情进展的预测效能。结果:大量白蛋白尿组血清肌酐(Scr)、血尿素氮(BUN)水平均明显高于微量白蛋白尿组,肾小球滤过率(GFR)低于微量白蛋白尿组(P<0.05);大量白蛋白尿组血清CER、SCCA水平均高于微量白蛋白尿组(P<0.05);经Pearson相关性分析,慢性肾功能衰竭患者血清CER、SCCA水平均与Scr、BUN呈正相关,与GFR呈负相关(P<0.05);经多因素Logistic回归分析,GFR、CER、SCCA均是慢性肾功能衰竭患者病情进展的独立预测因素(P<0.05);经ROC曲线分析,血清CER联合SCCA预测慢性肾功能衰竭患者病情进展的AUC为0.925,明显大于GFR的0.620(P<0.05)。结论:血清CER、SCCA水平与慢性肾功能衰竭患者肾功能呈负相关,联合预测病情进展效能较好,值得临床予以重视应用。 Objective:To analyze the relationship between ceruloplasmin(CER),squamous cell carcinoma associated antigen(SCCA)and chronic renal failure(CRF)and their predictive value for disease progression.Methods:A total of 169 patients with chronic renal failure admitted to our hospital from April 2019 to April 2021 were selected as the study subjects.According to 12 h urinary albumin quantification,the patients were divided into microalbuminuria group(<200 mg/24 h,102 cases)and macroalbuminuria group(>200 mg/24 h,67 cases).The laboratory indexes and serum CER and SCCA levels of the two groups were compared,and the relationship between CER,SCCA and renal function indexes of patients with chronic renal failure was analyzed.Patients were followed up for 24 months to observe the progression of the disease.Area under receiver operating Characteristic Curve(AUC)was used to evaluate the predictive efficacy of CER combined with SCCA on the progression of the disease.Results:The levels of serum creatinine(Scr)and blood urea nitrogen(BUN)in moderate proteinuria group were higher than those in mild proteinuria group,and the glomerular filtration rate(GFR)was lower than that in mild proteinuria group(P<0.05).The levels of CER and SCCA in moderate proteinuria group were higher than those in mild proteinuria group(P<0.05).Pearson correlation analysis showed that CER and SCCA levels were positively correlated with Scr and BUN,but negatively correlated with GFR(P<0.05).Multivariate Logistic regression analysis showed that GFR,CER and SCCA were independent predictors of chronic renal failure(P<0.05).According to ROC curve analysis,the AUC of CER combined with SCCA in predicting the progression of chronic renal failure was 0.926,which was significantly higher than 0.683 of GFR(P<0.05).Conclusion:The levels of CER and SCCA are negatively correlated with renal function in patients with chronic renal failure.The combined efficacy of CER and SCCA in predicting the progression of patients'disease is good and worthy of clinical attention.
作者 鲍楠 朱燕亭 张蓬杰 吴冰 常琳 BAO Nan;ZHU Yan-ting;ZHANG Peng-jie;WU Bing;CHANG Lin(Department of Nephrology,Shaanxi Provincial People's Hospital,Xi'an,Shaanxi,710068,China;Radio immunity Center,Shaanxi Provincial People's Hospital,Xi'an,Shaanxi,710068,China)
出处 《现代生物医学进展》 CAS 2023年第8期1596-1600,共5页 Progress in Modern Biomedicine
基金 陕西省自然科学基础研究计划项目(2021JQ-905)。
关键词 慢性肾功能衰竭 肾功能 铜蓝蛋白 鳞状细胞癌相关抗原 病情进展 Chronic renal failure Renal function Ceruloplasmin Squamous cell carcinoma associated antigen Disease progression
  • 相关文献

参考文献6

二级参考文献34

  • 1俞小芳,林静,徐夏莲,叶志斌.蛋白尿和血清白蛋白水平对血清肿瘤标志物水平的影响[J].复旦学报(医学版),2006,33(3):305-308. 被引量:5
  • 2Tramonti G,Ferdeghini M,Donadio C,et al.Renal function and serum concentration of five tumor in patients without evidence of neoplasia.Cancer Detect Prev,2000,24 (1):86.
  • 3Xiaofang Y,Yue Z,Xialian X,et al.Serum tumour markers in patients with chronic kidney disease.Scand J Clin Lab Invest,2007,67(6):661-667.
  • 4Kashiwabara K,Kishi K,Nakamura H,et al.Mechanism of increased serum cytokeratin 19 fragment levels in patients with diabetic nephropathy as a model of chronic renal failure.Internal Medicine,1998,37(11):917.
  • 5Marple JT,MacDougall M.Development of malignancy in the end-stage renal disease patient.Semin Nephrol,1993,13(3):306-314.
  • 6Birkeland SA,Lokkegaard H,Storm HH.Cancer risk in patients on dialysis and after renal transplantation.Lancet,2000,355 (9218):1886-1887.
  • 7Filella X,Cases A,Molina R,et al.Tumor markers in pathents with chronic renal failure.Int J Boil Markers,1990,5:85-88.
  • 8Arik N,Adam B,Akpolat T,et al.Serum tumor markers in renal failure.Int Urol Nephrol,1996,28:601-604.
  • 9王伟铭,陈永熙,陈楠.慢性肾脏病与肾脏纤维化和炎症[J].内科理论与实践,2007,2(6):417-419. 被引量:8
  • 10Nomura F, Koyama A, Ishijima M, et al. Serum levels of five tu- mor markers for lung cancer in patients with chronic renal failure [J].Oncol Rep, 1998,5(2) : 389.

共引文献22

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部